Kadimastem
A clinical stage biotech company using A cutting-edge TECHNOLOGY PLATFORM for the Development, Manufacturing, & Bio-Banking of human functional cells. Learn more
Launch date
Employees
Market cap
CAD10.0m
Enterprise valuation
CAD12m (Public information from Sep 2024)
Share price
ILS7.006 KDST.TA
Company register number 514192558
Sapir South District (HQ)
Authorizing premium user...